Internal Medicine COMAT Command Center Internal Medicine Shelf Exam Command Center

Acute Coronary Syndrome (ACS) encompasses a spectrum from Unstable Angina to Non-ST-Segment Elevation Myocardial Infarction (NSTEMI) and ST-Segment Elevation Myocardial Infarction (STEMI), driven by rupture or erosion of an atherosclerotic plaque with secondary occlusive thrombosis. In STEMI, transmural myocardial ischemia produces ST-segment elevations ≥ 1 mm in ≥ 2 anatomically contiguous leads (or ≥ 1.5–2.5 mm in leads V2–V3 depending on age/sex) or a new left bundle branch block. Coronary anatomy dictates lead localization: Anteroseptal MI (V1–V4, left anterior descending artery [LAD]); Lateral MI (I, aVL, V5, V6, left circumflex [LCx] or diagonal LAD); Inferior MI (II, III, aVF, right coronary artery [RCA]); and Posterior MI (ST depressions and tall R waves in V1–V3 with ST elevation in posterior leads V7–V9, LCx or RCA).

Immediate STEMI management demands urgent reperfusion therapy. Primary Percutaneous Coronary Intervention (PCI) is the gold standard, with a door-to-balloon target of ≤ 90 minutes at PCI-capable centers (or ≤ 120 minutes if requiring transfer). If transfer time exceeds 120 minutes, IV Thrombolytic therapy (Alteplase, Tenecteplase) is administered with a door-to-needle time of ≤ 30 minutes, followed by transfer for routine angiography. Immediate medical pharmacotherapy includes chewable Aspirin (325 mg), a P2Y12 inhibitor (Ticagrelor 180 mg or Prasugrel 60 mg, preferred over Clopidogrel), anticoagulation (Unfractionated Heparin or Enoxaparin), and high-intensity Statin (Atorvastatin 80 mg). Nitrates and morphine provide symptom relief, but are strictly contraindicated in right ventricular infarction.

Right Ventricular Infarction occurs in up to 40% of inferior STEMIs due to proximal RCA occlusion. The classic clinical triad is: (1) Hypotension, (2) Clear lung fields (absence of crackles or pulmonary edema), and (3) Marked Jugular Venous Distention (elevated CVP). Diagnosis is confirmed by obtaining right-sided precordial ECG leads, revealing ST elevation ≥ 1 mm in lead V4R. The ischemic right ventricle is preload-dependent; administration of Nitroglycerin, Morphine, or Diuretics abruptly reduces venous return, precipitating profound, life-threatening hypotension. Treatment requires immediate aggressive IV isotonic crystalloid volume loading (normal saline boluses) to maintain RV preload and inotropic support.

Cardiac dysrhythmias divide into narrow-complex tachycardias (QRS < 120 ms) and wide-complex tachycardias (QRS ≥ 120 ms). In any unstable tachyarrhythmia (hypotension, acute altered mental status, ischemic chest pain, pulmonary edema), the immediate treatment is Synchronized Cardioversion (NOT defibrillation, which is reserved for pulseless VT and VF). In stable narrow-complex supraventricular tachycardia (SVT/AVNRT), vagal maneuvers (modified Valsalva maneuver) are first-line, followed by rapid IV Adenosine (6 mg rapid push followed by 12 mg). Atrial Fibrillation requires immediate assessment of hemodynamic stability, rate vs. rhythm control (Beta-blockers like Metoprolol or CCBs like Diltiazem first-line for rate control; target resting HR < 110 bpm), and thromboembolic risk scoring using CHA2DS2-VASc. A score ≥ 2 in men (≥ 3 in women) mandates therapeutic oral anticoagulation with Direct Oral Anticoagulants (DOACs: Apixaban, Rivaroxaban) preferred over Warfarin.

Bradyarrhythmias and conduction blocks: First-degree AV block (prolonged PR > 200 ms, every P conducts) is benign and requires observation. Second-degree AV block Mobitz Type I (Wenckebach: progressive PR prolongation until a QRS drop) is nodal and usually asymptomatic. Second-degree AV block Mobitz Type II (intermittent dropped QRS without prior PR prolongation; infranodal His-Purkinje failure) carries a high risk of progression to Complete (Third-Degree) Heart Block (complete AV dissociation where P waves and QRS complexes beat independently at intrinsic escape rates 30–40 bpm). Mobitz Type II and Complete Heart Block are class I indications for urgent temporary transcutaneous/transvenous pacing followed by permanent pacemaker implantation.

Valvular Heart Disease: Aortic Stenosis (AS), driven by age-related calcification or congenital bicuspid aortic valve, presents classically with the triad of 'SAD': Syncope, Angina, and Dyspnea on exertion. Physical exam demonstrates a harsh crescendo-decrescendo systolic ejection murmur radiating to the carotids, single or paradoxically split S2, and pulsus parvus et tardus (weak, delayed carotid upstrokes). Symptomatic severe AS (aortic valve area ≤ 1.0 cm², mean gradient ≥ 40 mmHg) carries a 50% 2-year mortality if untreated; definitive management is emergent Transcatheter Aortic Valve Replacement (TAVR) or Surgical Aortic Valve Replacement (SAVR). Mitral Regurgitation presents with a blowing holosystolic murmur at the apex radiating to the axilla; acute severe MR (papillary muscle rupture 2–7 days post-MI) produces sudden cardiogenic pulmonary edema and hypotension requiring emergent surgical repair.

Cirrhosis results from chronic hepatic injury (alcohol, metabolic dysfunction-associated steatohepatitis [MASH], hepatitis C or B) leading to diffuse parenchymal nodularity and bridging fibrosis. Portal hypertension drives splanchnic vasodilation mediated by excess nitric oxide, producing decreased effective circulating arterial volume, activation of the renin-angiotensin-aldosterone system (RAAS), and renal sodium retention leading to ascites. Diagnostic paracentesis is mandatory for all patients hospitalized with new-onset or worsening ascites. Analysis includes cell count with differential, total protein, and calculation of the Serum-Ascites Albumin Gradient (SAAG = serum albumin minus ascitic fluid albumin). A SAAG ≥ 1.1 g/dL indicates Portal Hypertension (cirrhosis, congestive heart failure, Budd-Chiari syndrome); a SAAG < 1.1 g/dL indicates non-portal causes (peritoneal carcinomatosis, tuberculous peritonitis, nephrotic syndrome, pancreatitis).

Spontaneous Bacterial Peritonitis (SBP) is an acute bacterial infection of ascitic fluid occurring without an identifiable surgically treatable intra-abdominal source, resulting from bacterial translocation across the gut wall. Clinical presentation is often subtle: low-grade fever, mild abdominal pain, encephalopathy, or sudden worsening of renal function. SBP is definitively diagnosed when ascitic fluid absolute neutrophil count is ≥ 250 polymorphonuclear cells (PMNs)/µL. First-line empiric therapy is IV Cefotaxime or Ceftriaxone (2 g IV daily × 5 days). Intravenous Albumin (1.5 g/kg on day 1, and 1.0 g/kg on day 3) is MANDATORY in patients with BUN > 30 mg/dL, creatinine > 1.0 mg/dL, or total bilirubin > 4 mg/dL to prevent acute renal failure from type 1 hepatorenal syndrome and reduce mortality.

Hepatic Encephalopathy (HE) is a neurocognitive syndrome caused by failure of the cirrhotic liver to detoxify gut-derived neurotoxins, predominantly ammonia. It manifests along the West Haven criteria from subtle sleep-wake cycle reversal to asterixis ('flapping tremor' on dorsiflexion of wrists), confusion, and coma. HE is frequently precipitated by an acute stressor: GI bleeding (blood acts as a protein load), constipation, infection/SBP, electrolyte disturbances (hypokalemia promotes renal ammoniagenesis), or sedatives. First-line therapy is Lactulose (titrated to achieve 2–3 soft bowel movements daily; converted by colonic bacteria into lactic acid, trapping NH4+ in stool); Rifaximin is added as second-line therapy for recurrent episodes.

Acute Pancreatitis diagnosis requires ≥ 2 of the 3 revised Atlanta criteria: (1) Severe, persistent epigastric pain radiating directly to the mid-back; (2) Serum lipase or amylase ≥ 3× upper limit of normal (lipase is superior: more sensitive, specific, and remains elevated for 8–14 days); and (3) Characteristic findings on contrast-enhanced abdominal CT or MRI. If classic pain and ≥ 3× lipase elevation are present, diagnostic CT is NOT required on admission and should be deferred unless diagnostic uncertainty or failure to improve after 48–72 hours raises concern for pancreatic necrosis, pseudocyst, or abscess.

Initial management focuses on aggressive isotonic intravenous fluid resuscitation (Lactated Ringer's solution preferred over normal saline; 200–500 mL/hr, or 5–10 mL/kg/hr) to maintain adequate microvascular perfusion of the pancreatic parenchyma and prevent necrosis, monitoring urine output (> 0.5 mL/kg/hr) and hematocrit reduction. Mild acute pancreatitis warrants early oral feeding (low-fat solid or liquid diet as tolerated) as soon as abdominal pain improves and ileus resolves. Routine prophylactic intravenous antibiotics are NOT recommended for acute or sterile necrotizing pancreatitis; antibiotics (Meropenem or Ciprofloxacin + Metronidazole) are reserved strictly for confirmed infected necrosis (CT showing retroperitoneal gas bubbles or positive fine-needle aspirate gram stain/culture).

Peptic Ulcer Disease (PUD) is driven predominantly by Helicobacter pylori infection (> 70% duodenal, 50% gastric) and non-steroidal anti-inflammatory drugs (NSAIDs, which inhibit COX-1-mediated mucosal prostaglandin E2 synthesis). Duodenal ulcers classically cause epigastric pain relieved by food or antacids, recurring 2–4 hours after meals and at night. Gastric ulcers present with pain exacerbated by food intake, leading to food avoidance and weight loss. All gastric ulcers require follow-up endoscopy with repeat biopsy in 6–8 weeks to rule out underlying gastric adenocarcinoma. First-line eradication for H. pylori is Bismuth Quadruple Therapy × 14 days: Proton Pump Inhibitor (Omeprazole BID) + Bismuth subsalicylate + Metronidazole + Tetracycline. Eradication MUST be verified ≥ 4 weeks post-treatment using a urea breath test or stool antigen assay (patient must be off PPI for ≥ 2 weeks prior to testing).

Acute Kidney Injury (AKI) is classified into Prerenal, Intrinsic, and Postrenal etiologies. Prerenal azotemia results from hypoperfusion (hypovolemia, sepsis, heart failure, NSAIDs constricting afferent arterioles, ACE inhibitors dilating efferent arterioles). The renal tubules remain intact, avidly reabsorbing sodium and water: BUN/Creatinine ratio > 20:1, Urine Sodium < 20 mEq/L, Fractional Excretion of Sodium (FeNa) < 1% (or FeUrea < 35% if on loop diuretics), and urine specific gravity > 1.020 with hyaline casts. Intrinsic AKI is predominantly Acute Tubular Necrosis (ATN) caused by prolonged renal ischemia or nephrotoxins (aminoglycosides, IV iodinated contrast, vancomycin, cisplatin, myoglobin from rhabdomyolysis). In ATN, tubular epithelium is damaged, losing concentrated reabsorption: BUN/Cr ratio 10–15:1, Urine Sodium > 40 mEq/L, FeNa > 2%, and pathognomonic muddy brown granular casts.

Hyponatremia (serum sodium < 135 mEq/L) evaluation begins with serum osmolality to exclude Hypertonic (hyperglycemia; add 1.6–2.0 mEq/L Na for every 100 mg/dL glucose > 100) and Pseudohyponatremia (severe hyperlipidemia or paraproteinemia). True hypotonic hyponatremia is categorized by volume status: Hypovolemic (dehydration, diuretics; urine Na < 20 if extrarenal, > 20 if renal), Hypervolemic (CHF, cirrhosis, nephrotic syndrome), and Euvolemic (SIADH, primary polydipsia, secondary adrenal insufficiency, hypothyroidism). In SIADH, urine osmolality is inappropriately concentrated (> 100 mOsm/kg, usually > 300) and urine sodium is high (> 40 mEq/L). Safe correction is Paramount: serum sodium must NOT be corrected faster than 6 to 8 mEq/L in 24 hours to prevent Central Pontine Myelinolysis (Osmotic Demyelination Syndrome), which presents days later with dysarthria, dysphagia, quadriparesis, and 'locked-in' syndrome.

Hyperkalemia (serum potassium > 5.0 mEq/L; severe ≥ 6.5 mEq/L) represents an immediate cardiac electrical emergency. Progressive ECG changes evolve from tall, peaked T waves (earliest finding) to PR prolongation, loss of P waves, widening of the QRS complex, 'sine-wave' pattern, and ventricular fibrillation or asystole. Emergency management follows three sequential steps: (1) Cardiac membrane stabilization: IV Calcium Gluconate (10 mL of 10% solution over 2–3 minutes; stabilizes the cardiac sarcolemma within minutes without lowering serum potassium); (2) Intracellular potassium shifting: IV regular Insulin (10 units) with 50% Dextrose (50 mL D50), nebulized Albuterol (10–20 mg), and IV Sodium Bicarbonate (if metabolic acidosis present); and (3) Total body potassium elimination: Loop diuretics (Furosemide), potassium binders (Patiromer or Sodium Zirconium Cyclosilicate [Lokelma]), and emergent Hemodialysis for refractory hyperkalemia.

Glomerular disease partitions into Nephrotic syndromes (massive proteinuria > 3.5 g/day, hypoalbuminemia < 3.0 g/dL, generalized edema, hyperlipidemia, and lipiduria with 'Maltese cross' oval fat bodies) and Nephritic syndromes (hematuria with dysmorphic RBCs and RBC casts, variable sub-nephrotic proteinuria, hypertension, and azotemia). In adults, the most common nephrotic syndromes are Focal Segmental Glomerulosclerosis (FSGS: associated with African-American race, HIV, heroin use, obesity; podocyte effacement on EM), Membranous Nephropathy (associated with anti-PLA2R antibodies, hepatitis B/C, NSAIDs, solid tumors; 'spike-and-dome' subepithelial IgG/C3 deposits), and Diabetic Nephropathy (mesangial expansion and Kimmelstiel-Wilson nodular glomerulosclerosis).

Nephritic syndromes in adults: IgA Nephropathy (Berger disease) is the most common glomerulonephritis worldwide, presenting with recurrent macroscopic hematuria 1–2 days following a viral upper respiratory or GI infection ('synpharyngitic', distinguished from post-streptococcal GN which occurs 1–3 weeks after pharyngitis); renal biopsy demonstrates mesangial IgA and C3 deposition. Rapidly Progressive Glomerulonephritis (RPGN) is characterized by rapid loss of renal function over days to weeks with histologic cellular crescents (macrophages and fibrin) in Bowman's space. RPGN is categorized by immunofluorescence: (1) Linear anti-GBM (Goodpasture syndrome: anti-type IV collagen antibodies, pulmonary alveolar hemorrhage with hemoptysis and renal failure); (2) Granular immune-complex (SLE class IV lupus nephritis, PSGN); and (3) Pauci-immune negative IF (systemic ANCA vasculitides: Granulomatosis with Polyangiitis [c-ANCA / PR3], Microscopic Polyangiitis [p-ANCA / MPO]).

Acid-Base Interpretation follows a three-step rule: (1) Evaluate pH (acidemia < 7.35, alkalemia > 7.45); (2) Identify primary disorder by examining PaCO2 and HCO3-; and (3) Calculate the Anion Gap (AG = Na - [Cl + HCO3]; normal 8–12 mEq/L). In High Anion Gap Metabolic Acidosis (HAGMA), remember the mnemonic MUDPILES: Methanol, Uremia, DKA, Propylene glycol, Isoniazid/Iron, Lactic acidosis, Ethylene glycol, Salicylates. Check respiratory compensation in metabolic acidosis using Winter's formula: expected PaCO2 = 1.5 × HCO3- + 8 ± 2. If measured PaCO2 is higher than expected, a concomitant primary respiratory acidosis is present; if lower, a concomitant primary respiratory alkalosis is present.

Diabetic Ketoacidosis (DKA) is a life-threatening complication predominantly occurring in Type 1 Diabetes Mellitus, triggered by absolute insulin deficiency coupled with counter-regulatory hormone excess (glucagon, epinephrine, cortisol). Diagnostic triad: Hyperglycemia (blood glucose > 250 mg/dL), Anion Gap Metabolic Acidosis (pH < 7.30, serum bicarbonate < 18 mEq/L, anion gap > 12), and Ketonemia/Ketonuria (elevated beta-hydroxybutyrate). Patients present with Kussmaul respirations (rapid deep breathing to blow off CO2), fruity acetone breath, vomiting, and abdominal pain. Hyperosmolar Hyperglycemic State (HHS) occurs in Type 2 Diabetes, characterized by severe hyperglycemia (> 600 mg/dL), high serum osmolality (> 320 mOsm/kg), and profound dehydration (fluid deficit 8–10 L) in the ABSENCE of significant ketoacidosis (pH > 7.30, bicarb > 18).

DKA Resuscitation Algorithm: (1) Fluid resuscitation: 0.9% Normal Saline at 1 L/hr for the first 1–2 hours. Once hemodynamically stable, switch to 0.45% NS if corrected sodium is normal or high; (2) Potassium protocol: Insulin drives potassium into cells. If serum K < 3.3 mEq/L, HOLD insulin and replete potassium (20–40 mEq/hr) until K ≥ 3.3 mEq/L to prevent fatal cardiac arrest; if K is 3.3–5.2 mEq/L, give insulin AND add 20–30 mEq K per liter of IV fluid; if K > 5.2 mEq/L, give insulin and check K every 2 hours; (3) Regular Insulin infusion: 0.1 units/kg IV bolus followed by 0.1 units/kg/hr infusion (or 0.14 units/kg/hr continuous). When blood glucose drops to 200 mg/dL in DKA (or 300 mg/dL in HHS), add 5% Dextrose (D5 with 0.45% NS) to the infusion while continuing insulin to close the anion gap without precipitating hypoglycemia. DKA is resolved when: glucose < 200 mg/dL PLUS two of: serum bicarb ≥ 15 mEq/L, venous pH > 7.30, and anion gap ≤ 12.

Thyroid Storm is a hypermetabolic crisis in uncontrolled hyperthyroidism (Graves disease, toxic multinodular goiter), triggered by infection, trauma, or iodinated contrast. Patients present with high fever (> 38.5°C), marked tachycardia (> 140 bpm, atrial fibrillation), high-output heart failure, delirium, and diarrhea. Management requires four sequential pharmacologic steps: (1) Beta-blocker: Propranolol (blocks adrenergic hyperactivity and peripheral T4-to-T3 conversion); (2) Thionamide: Propylthiouracil (PTU, preferred in thyroid storm as it blocks new thyroid hormone synthesis AND peripheral T4-to-T3 conversion; Methimazole is second-line); (3) Saturated Solution of Potassium Iodide (SSKI / Lugol solution): administered at least 1 hour AFTER PTU to block hormone release via the Wolff-Chaikoff effect (giving iodine first worsens thyroid storm by providing substrate!); and (4) IV Glucocorticoids: Hydrocortisone (blocks peripheral T4-to-T3 conversion and treats relative adrenal insufficiency).

Microcytic Anemia (MCV < 80 fL) is categorized via iron studies: Iron Deficiency Anemia (IDA) is marked by low serum iron, elevated total iron-binding capacity (TIBC / transferrin), low ferritin (< 30 ng/mL; the most sensitive test), and elevated red cell distribution width (RDW). In men and postmenopausal women, IDA is colon cancer until proven otherwise, mandating upper endoscopy and colonoscopy. Anemia of Chronic Disease (ACD) is driven by IL-6 induced hepatic production of hepcidin (which internalizes ferroportin, sequestering iron inside macrophages): low serum iron, low or normal TIBC, normal or elevated ferritin (> 100 ng/mL), and normal RDW. Thalassemia Trait is characterized by profound microcytosis (MCV often < 70 fL) with completely normal iron studies, normal or elevated RBC count, low RDW (Mentzer index: MCV/RBC < 13 suggests thalassemia; > 13 suggests IDA), and abnormal hemoglobin electrophoresis (elevated HbA2 > 3.5% in beta-thalassemia minor). Sideroblastic Anemia (alcohol, lead toxicity, isoniazid/B6 deficiency) shows elevated serum iron and ferritin with ringed sideroblasts on Prussian blue bone marrow staining.

Thrombotic Thrombocytopenic Purpura (TTP) is a hematologic emergency resulting from severe deficiency of ADAMTS13 (a metalloproteinase that cleaves ultra-large von Willebrand factor multimers), usually caused by an acquired IgG autoantibody. Uncleaved vWF multimers promote massive platelet microthrombi in small vessels, causing end-organ ischemia and shearing erythrocytes. The classic pentad is: (1) Microangiopathic Hemolytic Anemia (MAHA: schistocytes on blood smear, high LDH, low haptoglobin, negative Coombs); (2) Severe Thrombocytopenia (often < 20,000/µL); (3) Neurologic deficits (confusion, headache, focal deficits); (4) Renal dysfunction; and (5) Fever. PT, PTT, and fibrinogen are strictly NORMAL (distinguishing TTP from DIC, which has prolonged PT/PTT and low fibrinogen). Immediate treatment is emergent Plasma Exchange (PLEX / plasmapheresis) combined with high-dose systemic Corticosteroids and Caplacizumab (anti-vWF nanobody). Platelet transfusions are STRICTLY CONTRAINDICATED as they fuel widespread microthrombosis.

Tumor Lysis Syndrome (TLS) is an oncologic emergency occurring after initiation of cytotoxic chemotherapy for high-turnover hematologic malignancies (Burkitt lymphoma, ALL, AML). Massive cell lysis floods circulation with intracellular contents, producing the classic metabolic tetrad: Hyperkalemia, Hyperphosphatemia, Hyperuricemia, and secondary Hypocalcemia (precipitation of calcium phosphate crystals in renal tubules). Patients develop acute uric acid nephropathy, cardiac arrhythmias, and tetany. Prophylaxis and treatment require aggressive IV hydration, Rasburicase (recombinant urate oxidase that converts uric acid to soluble allantoin; drug of choice in established TLS or high risk), or Allopurinol (xanthine oxidase inhibitor, used for low/moderate risk prophylaxis).

Community-Acquired Pneumonia (CAP) evaluation begins with severity stratification using the CURB-65 score: Confusion, Urea (BUN > 19 mg/dL), Respiratory rate ≥ 30/min, Blood pressure (systolic < 90 or diastolic ≤ 60 mmHg), and Age ≥ 65. Score 0–1 indicates outpatient management; score 2 indicates general inpatient admission; score ≥ 3 indicates consideration for ICU. Outpatient empiric therapy in healthy individuals without comorbidities: High-dose Amoxicillin (1 g TID) or Doxycycline (100 mg BID); in outpatients with comorbidities (COPD, diabetes, CHF, chronic renal failure): Amoxicillin-Clavulanate plus a Macrolide (Azithromycin) or respiratory Fluoroquinolone monotherapy (Levofloxacin, Moxifloxacin). Inpatient non-ICU therapy: IV Beta-lactam (Ceftriaxone 1–2 g IV daily or Ampicillin-Sulbactam) PLUS a Macrolide (Azithromycin) OR respiratory Fluoroquinolone monotherapy. For Hospital-Acquired Pneumonia (HAP, developing ≥ 48 hours post-admission), empiric broad-spectrum coverage must target MRSA (Vancomycin or Linezolid) AND Pseudomonas aeruginosa (Cefepime, Piperacillin-Tazobactam, or Meropenem).

Infective Endocarditis (IE) involves microbial infection of the cardiac valvular endothelium, most commonly the mitral valve in native valves (or tricuspid valve in intravenous drug users, where Staphylococcus aureus is the premier pathogen). Modified Duke Criteria require either 2 Major criteria, 1 Major + 3 Minor, or 5 Minor criteria. Major criteria: (1) Persistently positive blood cultures with typical organisms (S. aureus, Viridans group strep, Streptococcus gallolyticus [bovis, mandates colonoscopy for occult colon cancer], Enterococci, HACEK group); and (2) Evidence of endocardial involvement on echocardiography (oscillating intracardiac mass/vegetation on valve, abscess, new partial dehiscence of prosthetic valve, or new valvular regurgitant murmur). Minor criteria: predisposing heart condition or IVDU, fever ≥ 38.0°C, vascular phenomena (septic arterial emboli, mycotic aneurysms, intracranial hemorrhage, Janeway lesions: painless erythematous macules on palms/soles), and immunologic phenomena (Osler nodes: painful violaceous nodules on pads of fingers/toes, Roth spots: retinal hemorrhages with pale centers, glomerulonephritis, positive RF).

Acute Bacterial Meningitis in adults aged 18 to 50 is caused predominantly by Streptococcus pneumoniae and Neisseria meningitidis; in adults > 50 years, Listeria monocytogenes must be added. Empiric therapy for adults > 50: IV Vancomycin + Ceftriaxone (2 g IV q12h) + Ampicillin (for Listeria). In all suspected pneumococcal meningitis cases, IV Dexamethasone (10 mg IV) must be administered prior to or concurrently with the first dose of antibiotics to significantly reduce hearing loss and mortality.

Crystal Arthropathies present with acute, exquisite monoarthritis. Gout results from supersaturation and tissue deposition of Monosodium Urate (MSU) crystals, most commonly in the first metatarsophalangeal joint (podagra). Synovial fluid polarized light microscopy demonstrates Needle-shaped, strongly negatively birefringent crystals (yellow when parallel to the compensator axis, blue when perpendicular). Acute flare treatment: NSAIDs (Indomethacin), oral Colchicine (inhibits microtubule polymerization), or systemic Corticosteroids (first-line if renal disease or CHF contraindicates NSAIDs). Long-term urate-lowering therapy (Allopurinol, Febuxostat; xanthine oxidase inhibitors) targeting serum urate < 6.0 mg/dL is indicated for ≥ 2 flares/year, tophi, or CKD; allopurinol must NEVER be initiated during an acute flare without concomitant anti-inflammatory prophylaxis. Pseudogout (Calcium Pyrophosphate Dihydrate [CPPD] crystal deposition disease) classically affects the knee or wrist, often associated with hemochromatosis, hyperparathyroidism, or hypomagnesemia. Synovial fluid shows Rhomboid-shaped, weakly positively birefringent crystals (blue when parallel), with chondrocalcinosis (cartilage calcification) on radiographs.

Systemic Lupus Erythematosus (SLE) is a systemic autoimmune disease characterized by immune complex deposition affecting reproductive-aged women. Clinical features span the classic SLICC criteria: malar butterfly rash (sparing nasolabial folds), discoid rash, photosensitivity, painless oral ulcers, non-erosive arthritis, serositis (pleuritis, pericarditis), lupus nephritis (diffuse proliferative glomerulonephritis [class IV] is most severe), and hematologic cytopenias. Serologies: Antinuclear Antibodies (ANA) boast > 99% sensitivity (excellent screening test); Anti-double-stranded DNA (anti-dsDNA, correlates with active lupus nephritis and disease flares) and Anti-Smith (anti-Sm) have exceptional specificity (> 99%). All SLE patients should receive Hydroxychloroquine (reduces flare frequency, organ damage, and mortality; requires annual ophthalmologic screening for retinal toxicity).

Giant Cell (Temporal) Arteritis (GCA) is a large-vessel granulomatous vasculitis occurring in patients > 50 years, intimately linked with Polymyalgia Rheumatica (PMR: morning stiffness in bilateral shoulders and hips). GCA presents with new-onset unilateral headache, scalp tenderness, jaw claudication (pain with chewing due to maxillary artery ischemia), and amaurosis fugax (transient vision loss). Erythrocyte sedimentation rate (ESR) is markedly elevated, typically > 50 mm/hr (often > 100 mm/hr). Immediate initiation of high-dose systemic Corticosteroids (oral Prednisone 60 mg daily, or IV Methylprednisolone if vision changes are present) is MANDATORY to prevent permanent irreversible ischemic optic neuropathy (blindness) and must NEVER be delayed while waiting for temporal artery biopsy.